CannBioRx Total Cash From Financing Activities from 2010 to 2024

ATNFW Stock  USD 0.01  0.000012  0.15%   
CannBioRx Life Total Cash From Financing Activities yearly trend continues to be fairly stable with very little volatility. Total Cash From Financing Activities will likely drop to about 5.6 M in 2024. During the period from 2010 to 2024, CannBioRx Life Total Cash From Financing Activities regression line of quarterly data had mean square error of 993.2 T and geometric mean of  591,095. View All Fundamentals
 
Total Cash From Financing Activities  
First Reported
2018-03-31
Previous Quarter
-264.9 K
Current Value
-476.1 K
Quarterly Volatility
24.3 M
 
Covid
Check CannBioRx Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CannBioRx Life's main balance sheet or income statement drivers, such as Interest Expense of 42.59, Selling General Administrative of 7.6 M or Interest Income of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. CannBioRx financial statements analysis is a perfect complement when working with CannBioRx Life Valuation or Volatility modules.
  
Check out the analysis of CannBioRx Life Correlation against competitors.

Latest CannBioRx Life's Total Cash From Financing Activities Growth Pattern

Below is the plot of the Total Cash From Financing Activities of CannBioRx Life Sciences over the last few years. It is CannBioRx Life's Total Cash From Financing Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CannBioRx Life's overall financial position and show how it may be relating to other accounts over time.
Total Cash From Financing Activities10 Years Trend
Very volatile
   Total Cash From Financing Activities   
       Timeline  

CannBioRx Total Cash From Financing Activities Regression Statistics

Arithmetic Mean8,408,500
Geometric Mean591,095
Coefficient Of Variation361.43
Mean Deviation14,778,681
Median67,250
Standard Deviation30,391,044
Sample Variance923.6T
Range125.5M
R-Value0.04
Mean Square Error993.2T
R-Squared0
Significance0.89
Slope264,185
Total Sum of Squares12930.6T

CannBioRx Total Cash From Financing Activities History

20245.6 M
20235.9 M
202210.9 M
2020-8.7 M
20193.9 M
2018 4769.74
2017116.8 M

About CannBioRx Life Financial Statements

CannBioRx Life investors use historical fundamental indicators, such as CannBioRx Life's Total Cash From Financing Activities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CannBioRx Life. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Cash From Financing Activities5.9 M5.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.